This Is MS Multiple Sclerosis Community: Knowledge & Support

Sanofi SA has won U.S. approval for its multiple sclerosis pill Aubagio - one of the two treatments for the chronic disease that could return the French drugmaker to growth after several blockbuster drugs lost patent protection.

The drug has been shown to be less effective than some rivals but has milder side effects and analysts say it could find favour among newly diagnosed patients. Around 35 percent to 40 percent of multiple sclerosis (MS) sufferers prefer to take no medication rather than face unwanted side effects.

"In a clinical trial, the relapse rate for patients using Aubagio was about 30 percent lower than the rate for those taking a placebo," Russell Katz, director of the Division of Neurology Products at the Food and Drug Administration, said in a statement on Wednesday.

Aubagio is expected to launch on the U.S. market in a few weeks, a spokeswoman for Sanofi unit Genzyme said.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2933

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis

Thank you for that post squiffy.

I wonder if that is good news or not. My doc say's he's waiting for BG-12, he didn't mention anything about Aubagio. If anyone here is informed, it would be great to hear your comments.


Edit: Oups, should have looked in the Drug Pipeline board. There is quite a few posts about Aubagio when you look under it's former name teriflunomide.

Hi Sophie

MSRC has dedicated pages to both Aubagio and BG-12 as well as all the other MS drugs under investigation, you can find them via this page - http://www.msrc.co.uk/index.cfm/fuseact ... pageid/683

squiffs

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis